• 中国中文核心期刊
  • 中国科学引文数据库核心期刊
  • 中国科技核心期刊
  • 中国高校百佳科技期刊
高级检索

抗肿瘤NEDD8活化酶抑制剂的研究进展

郭亚辉, 陆鹏, 王玉斌, 张惠斌

郭亚辉, 陆鹏, 王玉斌, 张惠斌. 抗肿瘤NEDD8活化酶抑制剂的研究进展[J]. 中国药科大学学报, 2017, 48(6): 646-653. DOI: 10.11665/j.issn.1000-5048.20170603
引用本文: 郭亚辉, 陆鹏, 王玉斌, 张惠斌. 抗肿瘤NEDD8活化酶抑制剂的研究进展[J]. 中国药科大学学报, 2017, 48(6): 646-653. DOI: 10.11665/j.issn.1000-5048.20170603
GUO Yahui, LU Peng, WANG Yubin, ZHANG Huibin. Progress in the researches for antitumor NEDD8 activating enzyme inhibitors[J]. Journal of China Pharmaceutical University, 2017, 48(6): 646-653. DOI: 10.11665/j.issn.1000-5048.20170603
Citation: GUO Yahui, LU Peng, WANG Yubin, ZHANG Huibin. Progress in the researches for antitumor NEDD8 activating enzyme inhibitors[J]. Journal of China Pharmaceutical University, 2017, 48(6): 646-653. DOI: 10.11665/j.issn.1000-5048.20170603

抗肿瘤NEDD8活化酶抑制剂的研究进展

Progress in the researches for antitumor NEDD8 activating enzyme inhibitors

  • 摘要: NEDD8活化酶(NAE)是Neddylation过程中的限速酶,抑制NAE的活性,能够降低泛素-蛋白酶体系统(UPS)通路的活性和相关蛋白的降解,诱导肿瘤细胞凋亡。与蛋白酶体抑制剂相比,NAE抑制剂对干扰细胞内环境稳态更有特异性。随着对NAE研究的不断深入,多种NAE抑制剂已被报道。根据这些NAE抑制剂的结构特点,可分为AMP类似物、双黄酮类脱氧鸭嘴花碱酮衍生物和金属铑络合物类等。本文介绍了类泛素化修饰Neddylation过程,其限速酶NAE与肿瘤的生理作用,并综述了NAE抑制剂的最新研究进展。
    Abstract: Inhibition of NEDD8 activating enzyme(NAE), the rate limiting enzyme in Neddylation, can suppress the activity of ubiquitin-proteasome system(UPS)pathway and decrease degradations of related proteins, resulting in cell apoptosis. Compared with the proteasome inhibitors, NAE inhibitors can interfere with cellular homeostasis with more specificity. With the rapid development of the research on NAE, a variety of NAE inhibitors have been reported. According to the structure characteristics, NAE inhibitors can be divided into the AMP analogues, double flavonoids deoxidization duckbill alkali ketone derivatives and metal rhodium complex classes, etc. The process of ubiquitinated modified Neddylation, NAE and physiological role of tumor has been introduced in this paper, and the latest progress of NAE inhibitors also has been summarized.
  • [1] Hershko A. The ubiquitin system for protein degradation and some of its roles in the control of the cell-division cycle(Nobel Lecture)[J].Angew Chem Int Ed Engl,2005,44(37):5932-5943.
    [2] Buckley DL,Crews CM.Small-molecule control of intracellular protein levels through modulation of the ubiquitin proteasome system[J].Angew Chem Int Ed Engl,2014,53(9):2312-2330.
    [3] da Silva SR,Paiva SL,Lukkarila JL,et al.Exploring a new frontier in cancer treatment:targeting the ubiquitin and ubiquitin-like activating enzymes[J].J Med Chem,2013,56(6):2165-2177.
    [4] Bedford L,Lowe J,Dick LR,et al.Ubiquitin-like protein conjugation and the ubiquitin-proteasome system as drug targets[J].Nat Rev Drug Discov,2011,10(1):29-46.
    [5] Wang SM, Sun W, Zhao YJ, et al. SAR405838:an optimized inhibitor of MDM2-p53 interaction that induces complete and durable tumor regression[J].Cancer Res,2014,74(20):5855-5865.
    [6] Kee Y,Huibregtse JM.Regulation of catalytic activities of HECT ubiquitin ligases[J].Biochem Biophys Res Commun,2007,354(2):329-333.
    [7] Hatakeyama S,Nakayama KI.U-box proteins as a new family of ubiquitin ligases[J].Biochem Biophys Res Commun,2003,302(4):635-645.
    [8] Podust VN,Brownell JE,Gladysheva TB,et al.A Nedd8 conjugation pathway is essential for proteolytic targeting of p27Kip1 by ubiquitination[J].Proc Natl Acad Sci U S A,2000,97(9):4579-4584.
    [9] Read MA,Brownell JE,Gladysheva TB,et al.Nedd8 modification of cul-1 activates SCF(beta(TrCP))-dependent ubiquitination of IkappaBalpha[J].Mol Cell Biol,2000,20(7):2326-2333.
    [10] Soucy TA,Dick LR,Smith PG,et al.The Nedd8 conjugation pathway and its relevance in cancer biology and therapy[J].Genes Cancer,2010,1(7):708-716.
    [11] Pan ZQ,Kentsis A,Dias DC,et al.Nedd8 on cullin:building an expressway to protein destruction[J].Oncogene,2004,23(11):1985-1997.
    [12] Read MA,Brownell JE,Gladysheva TB,et al.Nedd8 modification of Cul-1 activates SCF β TrCP -dependent ubiquitination of IκBα[J].Mol Cell Biol,2000,20(7):2326-2333.
    [13] Boh BK,Smith PG,Hagen T.Neddylation-induced conformational control regulates cullin RING ligase activity in vivo[J].J Mol Biol,2011,409(2):136-145.
    [14] Xie P,Zhang MH,He SA,et al.The covalent modifier Nedd8 is critical for the activation of Smurf1 ubiquitin ligase in tumorigenesis[J].Nat Commun,2014,5(6183):3733.
    [15] Kumar S,Yoshida Y,Noda M.Cloning of a cDNA which encodes a novel ubiquitin-like protein[J].Biochem Biophys Res Commun,1993,195(1):393-399.
    [16] Kamitani T,Kito K,Nguyen HP,et al.Characterization of NEDD8,a developmentally down-regulated ubiquitin-like protein[J].J Biol Chem,1997,272(45):28557-28562.
    [17] Rabut G,Peter M.Function and regulation of protein Neddylation.′Protein modifications:beyond the usual suspects′ review series[J].EMBO Rep,2008,9(10):969-976.
    [18] Salon C,Brambilla E,Brambilla C, et al.Altered pattern of Cul-1 protein expression and Neddylation in human lung tumours:relationships with CAND1 and cyclin E protein levels[J].J Pathol,2007,213(3):303-310.
    [19] Mori F,Nishie M,Piao YS,et al.Accumulation of NEDD8 in neuronal and glial inclusions of neurodegenerative disorders[J].Neuropathol Appl Neurobiol,2005,31(1):53-61.
    [20] Chairatvit K,Ngamkitidechakul C.Control of cell proliferation via elevated NEDD8 conjugation in oral squamous cell carcinoma[J].Mol Cell Biochem,2007,306(1):163-169.
    [21] DilKuazi A,Kito K,Abe Y,et al.NEDD8 protein is involved in ubiquitinated inclusion bodies[J].J Pathol,2003,199(2):259-266.
    [22] Li LH,Wang MS,Yu GY,et al.Overactivated Neddylation pathway as a therapeutic target in lung cancer[J].J Natl Cancer Inst,2014,106(6):dju083.
    [23] Gao Q,Yu GY,Shi JY,et al.Neddylation pathway is up-regulated in human intrahepatic cholangiocarcinoma and serves as a potential therapeutic target[J].Oncotarget,2014,5(17):7820-7832.
    [24] Cheng F,Chen H,Zhang L,et al.Inhibition of the NEDD8 conjugation pathway by shRNA to UBA3,the subunit of the NEDD8-activating enzyme,suppresses the growth of melanoma cells[J].Asian Pac J Cancer Prev,2012,13(1):57-62.
    [25] Wang M,Medeiros BC,Erba HP,et al.Targeting protein Neddylation:a novel therapeutic strategy for the treatment of cancer[J].Exp Opin Ther Targets,2011,15(3):253-264.
    [26] Soucy TA,Smith PG,Milhollen MA,et al.An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer[J].Nature,2009,458(7239):732-736.
    [27] Zhao LP,Yue P,Lonial S,et al.The NEDD8-activating enzyme inhibitor,MLN4924,cooperates with TRAIL to augment apoptosis through facilitating c-FLIP degradation in head and neck cancer cells[J].Expert Opin Ther Targets,2011,10(12):2415-2425.
    [28] Swords RT,Kelly KR,Smith PG,et al.Inhibition of NEDD8-activating enzyme:a novel approach for the treatment of acute myeloid leukemia[J].Blood,2010,115(18):3796-3800.
    [29] Wei DP,Li H,Yu J,et al.Radiosensitization of human pancreatic cancer cells by MLN4924,an investigational NEDD8-activating enzyme inhibitor[J].Cancer Res,2012,72(1):282-293.
    [30] Brownell JE, Sintchak MD, Gavin JM, et al. Substrate-assisted inhibition of ubiquitin-like protein-activating enzymes:the NEDD8 E1 inhibitor MLN4924 forms a NEDD8-AMP mimetic in situ[J].Mol Cell,2010,37(1):102-111.
    [31] Julie LL, Sara RS, Mohsia A, et al. Identification of NAE inhibitors exhibiting potent activity in leukemia cells:exploring the structural determinants of NAE specificity[J].ACS Med Chem Lett,2011,2(8):577-582.
    [32] Heeseon A, Alexander VS. An inhibitor of ubiquitin conjugation and aggresome formation[J].Chem Sci,2015,6(9):5235-5245.
    [33] Leung CH,Chan DS,Yang H,et al.A natural product-like inhibitor of NEDD8-activating enzyme[J].Chem Commun,2011,47(9):2511-2513.
    [34] Zhong HJ,Ma VP,Cheng Z,et al.Discovery of a natural product inhibitor targeting protein Neddylation by structure-based virtual screening[J].Biochimie,2012,94(11):2457-2460.
    [35] Zhong HJ,Yang H,Chan DS,et al.A metal-based inhibitor of NEDD8-activating enzyme[J].PLoS ONE,2012,7(11):e49574.
    [36] Zhang SP,Tan JN,Lai ZH,et al.Effective virtual screening strategy toward covalent ligands:identification of novel NEDD8-activating enzyme inhibitors[J].J Chem Inf Model,2014,54(6):1785-1797.
    [37] Baell J,Walters MA.Chemistry:chemical con artists foil drug discovery[J].Nature,2014,513(7519):481-483.
    [38] Zhong HJ,Liu LJ,Chan SH,et al.Structure-based repurposing of FDA-approved drugs as inhibitors of NEDD8-activating enzyme[J].Biochimie,2014,102(1):211-215.
    [39] Lu P,Liu XX,Yuan XR,et al.Discovery of a novel NEDD8 activating enzyme inhibitor with piperidin-4-amine Scaffold by structure-based virtual screening[J].ACS Chem Biol,2016,11(7):1901-1907.
计量
  • 文章访问数:  1100
  • HTML全文浏览量:  1
  • PDF下载量:  2937
  • 被引次数: 0
出版历程
  • 刊出日期:  2017-12-24

目录

    /

    返回文章
    返回
    x 关闭 永久关闭